RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Cystic Fibrosis Foundation
C

Cystic Fibrosis Foundation portfolio

Cystic Fibrosis Foundation has 2 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $52M.
Latest deal: Pulmocide · Dec 6, 2022.
About this page

Its most recent investment on record is Pulmocide's $52M Series B+ round in December 2022, alongside Pictet Alternative Advisors, Longwood Fund, Johnson & Johnson Innovation and 6 others. By category, its portfolio leans toward Health and bio (2).

What Cystic Fibrosis Foundation invests in

How Cystic Fibrosis Foundation invests

StageDealsCapital in rounds
Series B+ 1 100%$52M

Cystic Fibrosis Foundation portfolio companies

CompanyRound with Cystic Fibrosis FoundationTotal raisedLatest raise
PPulmocide
Health and bio
Series B+ · $52M$174.4MDec 6, 2022
Series B+
PPeptilogics
Health and bio
backer$118.9MOct 16, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Cystic Fibrosis Foundation. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Cystic Fibrosis Foundation, which is a subset of its real portfolio. API: /api/v1/investors/cystic-fibrosis-foundation (get a free API key). More: the most active VC firms and new venture capital funds.